Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02559102
Other study ID # SHF/CTG055/2014
Secondary ID
Status Completed
Phase Phase 3
First received
Last updated
Start date July 2015
Est. completion date January 31, 2021

Study information

Verified date March 2017
Source KK Women's and Children's Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a prospective randomized controlled trial comparing dexmedetomidine sedation with caudal anaesthesia, and general sevoflurane anaesthesia with caudal anaesthesia for inguinal herniotomies in neonates and infants below 3 months of age. The investigators will compare the efficacy and adverse events associated with each of these techniques and neurodevelopmental outcomes of the infants in each group at 6 months and 2 years of age.


Description:

Several epidemiologic studies have suggested that children exposed to general anaesthesia (GA) in early childhood may be at increased risk of subsequent learning disabilities and behavioural problems. Animal studies have shown that exposure to GA agents during critical neuro-developmental windows induces neuronal apoptosis. All commonly used anaesthetic agents induce neurotoxicity with the exception of dexmedetomidine, a highly specific alpha-2 agonist which has been shown to be neuroprotective. GA is the current standard of care for inguinal hernia repair in infants at KKH. The investigators recently demonstrated that dexmedetomidine sedation with caudal block is a feasible alternative for inguinal hernia repair in infants below 3 months of age. This prospective randomized controlled trial will compare the early and long-term outcomes of infants following inguinal hernia surgery using dexmedetomidine sedation with caudal block versus GA with caudal block. This study aims: 1. To compare the neurodevelopment at 6 months and 2years, of infants randomized to dexmedetomidine sedation with caudal block with those randomized to GA with caudal block for inguinal hernia surgery before 3 months of age. 2. To compare the efficacy of dexmedetomidine sedation with caudal block versus GA with caudal block for inguinal hernia surgery, in terms of duration of anaesthesia, duration of surgery and surgeon's satisfaction with intraoperative conditions.


Recruitment information / eligibility

Status Completed
Enrollment 104
Est. completion date January 31, 2021
Est. primary completion date July 20, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 34 Weeks to 54 Weeks
Eligibility Inclusion Criteria: - Infants below 3 months of age ( corrected age 54 weeks) presenting for elective inguinal hernia repair in KKH. Exclusion Criteria: - History of prematurity younger than 28 weeks gestation, - Requirement for CPAP greater than 6 cmH20 at time of surgery - Significant cardiac pathology or cardiac conduction defects - Unusually large hernia sacs - Any contraindication for caudal anesthesia - Surgeon refusal on account of anticipated prolonged or difficult surgery.

Study Design


Intervention

Drug:
Dexmedetomidine sedation
Patients receive dexmedetomidine sedation
General sevoflurane anaesthesia
Patients receive general sevoflurane anaesthesia with endotracheal intubation
Procedure:
Caudal anaesthesia
single shot caudal anaesthesia
Inguinal hernia surgery
Infant inguinal hernia repair.

Locations

Country Name City State
Singapore KK Women's and Children's Hospital Singapore

Sponsors (4)

Lead Sponsor Collaborator
KK Women's and Children's Hospital Duke-NUS Graduate Medical School, Singapore Institute for Clinical Sciences, Singhealth Foundation

Country where clinical trial is conducted

Singapore, 

References & Publications (3)

Jevtovic-Todorovic V, Hartman RE, Izumi Y, Benshoff ND, Dikranian K, Zorumski CF, Olney JW, Wozniak DF. Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits. J Neurosci. 2003 Feb 1;23(3):876-82. — View Citation

Mahmoud M, Mason KP. Dexmedetomidine: review, update, and future considerations of paediatric perioperative and periprocedural applications and limitations. Br J Anaesth. 2015 Aug;115(2):171-82. doi: 10.1093/bja/aev226. Review. — View Citation

Sanders RD, Sun P, Patel S, Li M, Maze M, Ma D. Dexmedetomidine provides cortical neuroprotection: impact on anaesthetic-induced neuroapoptosis in the rat developing brain. Acta Anaesthesiol Scand. 2010 Jul;54(6):710-6. doi: 10.1111/j.1399-6576.2009.02177.x. Epub 2009 Dec 9. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Surgical success rate Success rate of surgery with assigned technique, without requiring further adjuvants. 4 hours
Other Peri-operative apnea episodes Number of episodes of apnea intra-operatively, in PACU, and in ward. 24 hours
Other Peri-operative bradycardic episodes Number of episodes of bradycardia intra-operatively, in PACU, and in ward. 24 hours
Primary Deferred Imitation scores at 6 months Deferred imitation, test of declarative memory. Infants are assessed when first shown the "target" actions (DF1) and again on how well they reproduce the actions (DF2). 6 months
Secondary Bayley scores at 2 years Bayleys scales of Infant Development version III 2 years
See also
  Status Clinical Trial Phase
Completed NCT02909959 - Sulforaphane for the Treatment of Young Men With Autism Spectrum Disorder Phase 2
Completed NCT02757079 - Study of the Efficacy and Safety of NPC-15 for Sleep Disorders of Children With Neurodevelopmental Disorders Phase 3
Active, not recruiting NCT01942525 - Influence of Intrauterine Growth Restriction on Amplitude-integrated EEG in Preterm Infants N/A
Completed NCT00503191 - NeuroModulation Technique Treatment of Autism Phase 1
Not yet recruiting NCT06442592 - Characterization and Support for Neurodevelopmental Disorders Associated With Congenital Heart Defects N/A
Completed NCT01783041 - Effect of Early L-Carnitine Supplementation on Neurodevelopmental Outcomes in Very Preterm Infants Phase 2/Phase 3
Recruiting NCT01850784 - High Energy Formula Feeding in Infants With Congenital Heart Disease N/A
Terminated NCT02557191 - Biomarkers, Neurodevelopment and Preterm Infants